The Philippine Economic Zone Authority (PEZA) recently met with Unilab Inc. to explore potential economic zone investment opportunities, particularly under the CREATE MORE regime.
PEZA director-general Tereso Panga noted PEZA’s strategic partnership with the Food and Drug Administration (FDA), which includes an exclusive green lane arrangement for Food and Drug Administration (FDA)-related processes for PEZA locators.
The new process and PEZA’s one-stop-shop facility are expected to enhance ease of doing business for pharmaceutical companies like Unilab within the ecozones.
PEZA has been boosting efforts to attract investments in the pharmaceutical and medical sectors, in line with President Ferdinand Marcos Jr.’s directive to localize and reduce the cost of medicines for Filipinos.
A Filipino pharma conglomerate, Unilab specializes in a wide range of consumer healthcare products, including prescription and over-the-counter medications, vitamins, food supplements, and biotechnology.
The Campos family, the largest shareholder in Unilab, has other successful ecozone ventures with PEZA. These include the Philippine Packing Agricultural Export Processing Zone, which houses the operations of Del Monte Foods and JY Campos IT Centre, home to Convergys, a major IT investor in the country.
